Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03677882 · ClinicalTrials.gov registry record · NA
A Brief Mind-Body Bridging Intervention for Suicidal Ideation
A NA study, sponsored by VA Salt Lake City Health Care System.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT03677882: Clinical Trial NA study, sponsored by VA Salt Lake City Health Care System.
NCT03677882 is a NA study that was terminated before completion, run by VA Salt Lake City Health Care System. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03677882, a NA study, was terminated before completion, sponsored by VA Salt Lake City Health Care System.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The aim of this study is to determine whether a Brief Mind-Body Bridging Intervention for Suicidal Ideation (MBB-SI) will result in short or longer-term reduction of psychological factors associated with suicidal ideation (SI) and/or suicide-related behaviors (SRB's) compared to Treatment as Usual (TAU).
Primary Outcome
Determine if there is a significant difference in the frequency and/or intensity of suicidal ideation, as measured by the Beck Scale for Suicide Ideation (BSS) among the MBB-SI + TAU cohort compared to the TAU. We will use the total BSS score, ranging from 0 to 38. Increased scores reflect greater suicide risk.
Interventions
- BEHAVIORAL Mind Body Bridging Group Session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2018-12-18 |
| Est. Completion | 2023-01-31 |
| Phase | NA |
Why NCT03677882 stopped before completion
NCT03677882 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Mind Body Bridging Group Session is the first listed.
NCT03677882 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03677882 about?
NCT03677882 is a clinical study titled "A Brief Mind-Body Bridging Intervention for Suicidal Ideation". The aim of this study is to determine whether a Brief Mind-Body Bridging Intervention for Suicidal Ideation (MBB-SI) will result in short or longer-term reduction of psychological factors associated with suicidal ideation (SI) and/or suicide-related behaviors (SRB's) compared to Treatment as Usual (...
What is the current status of trial NCT03677882?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2018-12-18. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT03677882?
The interventions under investigation include: Mind Body Bridging Group Session (BEHAVIORAL).
Who is sponsoring clinical trial NCT03677882?
This trial is sponsored by VA Salt Lake City Health Care System, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03677882's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI